Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
65.33
+4.04 (6.59%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Tarsus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $92.88. The average 1-year stock price forecast is 42.17% higher than the current stock price, while the lowest is $84 (+28.58%) and the highest is $104 (+59.19%).
Price Target: $92.88 (+42.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tarsus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $98 | Buy | Maintains | $98 | +50.01% | Aug 4, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $97 | Buy | Maintains | $97 | +48.48% | Jul 21, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $90 → $89 | Buy | Maintains | $90 → $89 | +36.23% | Jul 21, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 14, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +45.42% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
714.21M
from 451.36M
Increased by 58.24%
Revenue Next Year
895.51M
from 714.21M
Increased by 25.38%
EPS This Year
-1.63
from -1.59
EPS Next Year
2.34
from -1.63
EPS and Forward PE are based on non-GAAP adjusted numbers.